BRIEF — Sanofi, pCPA Sign Letter Of Intent For Dupixent® Across Four Indications In Dermatology, Respiratory Care

Oct 15 (Reuters) — Sanofi SA: Sanofi And Pcpa Sign Letter Of Intent For Dupixent® Across Four Indications In Dermatology And Respiratory Care To Support Patient Access To Dupixent Via Public Drug Plans In Canada Source text:... Further company coverage: SASY.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;)